Red neck syndrome which is a
side effect of vancomycin, is associated with excessive release of histamine and
is sometimes a life threatening complication. In patients who develop
red
neck syndrome, if necessary, vancomycin therapy may be continued with
corticosteroids and antihistamines or an alternative antibiotic may be started.
In this report, a 54 year-old female patient who was
started vancomycin therapy because of penicillin resistant pneumococcal
meningitis and developed red neck syndrome on 8th day of the therapy was
presented. It was learned that the patient's vancomycin infusion that morning
was shorter than one hour. Vancomycin therapy was stopped and intravenous
linezolide was started. In conclusion, red neck syndrome may develop due to rapid
infusion of vancomycin. In this patients linezolide may be used as alternative
therapy.
Penicillin resistant pneumococcus meningitis vancomycin side effect red neck syndrome management
Vankomisine bağlı olarak gelişen yan etkilerden
red neck (kırmızı boyun) sendromu histamin aşırı salınımına bağlı bazen hayatı
tehdit edebilen bir komplikasyondur. Red neck sendromu gelişen hastalarda zorunlu
hallerde kortikosterod ve antihistaminiklerle birlikte vankomisin tedavisine
devam edilebilir veya alternatif bir antibiyotik tedavisine geçilebilir. Bu
yazıda, penisiline dirençli pnömokok menenjiti tanısıyla vankomisin tedavisi
başlanan ve tedavinin 8. gününde red neck sendromu gelişen 54 yaşında bir kadın
hasta sunuldu. Hastanın o sabah verilen vankomisin infüzyonunun bir saatten kısa
sürdüğü öğrenildi. Hastanın vankomisin
tedavisi kesilerek intravenöz linezolid tedavisine geçildi.
Sonuç olarak, vankomisinin hızlı infüzyonuna bağlı olarak red neck
sendromu gelişebilir ve bu olgularda tedavi yönetiminde alternatif ilaç olarak
linezolid kullanılabilir.
Penisiline dirençli pnömokok menenjit vankomisin yan etki red neck sendromu tedavi yönetimi
Primary Language | Turkish |
---|---|
Subjects | Health Care Administration |
Journal Section | Case Report |
Authors | |
Publication Date | January 25, 2019 |
Published in Issue | Year 2019 Volume: 2 Issue: 1 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.